N onalcoholic fatty liver disease (NALFD) is a prevalent cause of chronic liver disease, and affects more than 100 million individuals in the United States alone. 1 Studies have shown that fibrosis in patients NAFLD is a positive predictor of worsening liver-related morbidity and mortality. 2 Liver biopsy is the current gold standard in the evaluation of hepatic disease, especially in cases with unclear underlying diagnoses. However, its utility has been limited due to the invasive nature of testing. 3, 4 Recent studies have focused on endoscopic ultrasound (EUS) liver biopsies and their significant potential in diagnosing hepatic malignancies. 5, 6 Magnetic imaging elastography (MRE) has emerged as in accurate means to assess severity of liver fibrosis. Thus, the primary aim of our study was to evaluate the diagnostic accuracy of the 19-gauge needle (SharkCore, Medtronic, Sunnyvale, CA) with a modified one-pass wet suction technique (EUS-modified liver biopsy [EUS-MLB]) compared with MRE in identifying and staging patients with fatty liver.
Methods
We performed a retrospective chart review of consecutive patients who underwent EUS-MLB and MRE at Baptist Medical Center between April 2015 and October 2016. The permission to obtain retrospective review and publication of data was exempted by the Institutional Review Board. Patients were referred for EUS to evaluate for structural biliary tract disease as a cause of abnormal liver-associated tests. If the EUS exam did not determine that pancreatobiliary disease or other focal abnormalities were present, a decision was made to perform EUS-MLB.
Echoendoscopy was performed using a standard linear-array echoendoscope (GF-UE160-AL5, Olympus America, Center Valley, PA). EUS-MLB under real-time ultrasound guidance was performed by using a commercially available 19-gauge needle (SharkCore). The left lobe of the liver was accessed by transgastric route and the right lobe was accessed by transduodenal route.
We measured the maximum intact core tissue length, total specimen length (TSL), and total number of complete portal tracts (CPTs). A comparison was performed between the histological diagnosis and fibrosis score based on MRE. The fibrosis score ranges from 0 to 4. Agreement between MRE and EUS-MLB fibrosis grade was summarized using accuracy and Spearman's rank correlation coefficient.
Results
A total of 47 patients were included in the study, with most patients (66%) being women. The median age was 54 years and the average body mass index was 30.1. The median TSL was 6.5 (interquartile range, 4.6-8) cm. The median CPTs per TSL was 18 (interquartile range, 14-24). All but 2 patients (45 of 47 [95.7%]) had more than 10 CPTs on the biopsy specimen. Of the 47 patients in the study, 39 (83.0%) had concordance in severity of fibrosis staging seen on EUS-MLB and MRE. Six of the discordant patients were within 1 fibrosis grade of the 2 techniques. Two patients had self-limited liver hematomas that resolved with conservative management.
Correlation and distribution of fibrosis grade between MRE and EUS-MLB are presented in Figure 1 . The Pearson correlation showed a positive correlation of 0.815 and accuracy of 83.3 between the 2 methods for identifying the same fibrosis grade.
Discussion
The results of our study demonstrate not only the adequacy of EUS-MLB in diagnosing NAFLD, but also the histologic accuracy in staging fibrosis as compared with MRE with Pearson correlation score of 0.815. Of the 47 patients who underwent EUS-MLB, 39 (83.0%) had significant positive correlation in the severity of liver fibrosis seen on biopsy and the calculated fibrosis score based on MRE. The prognosis of fibrosis development in NAFLD and the transition to nonalcoholic steatohepatitis has significant implications for morbidity and mortality, and therefore the ability to accurately predict fibrosis presence is key.
The formal definition of adequate liver biopsy sampling varies among different organizations, with the most stringent guidelines from American Association for the Study of Liver Diseases with a recommended length of 2.0 cm or 11 CPTs. 8 All patients in our cohort met at least 1 of these parameters for adequacy. The diagnostic yield was 100% in the 47 patients who underwent EUS-MLB with the novel 19-gauge guided core biopsy needle using a modified one-pass wet suction technique.
The results of our study demonstrate that EUS-MLB is a safe and accurate way to assess for the presence and severity of fibrosis in patients with fatty liver disease. In patients who are referred for EUS for abnormal liver tests or evaluation of hepatobiliary disease, consideration of concomitant liver biopsy using our technique can be a cost-effective and feasible option. Figure 1 . Correlation between endoscopic ultrasoundmodified liver biopsy and magnetic imaging elastography fibrosis grade. F-score, fibrosis score; MRI, magnetic resonance imaging; S-score, stage.
